Publications by authors named "M Barthwal"
Doege Potter syndrome in patient with solitary fibrous tumor of the pleura.
Med J Armed Forces India
December 2024
Solitary fibrous tumors of pleura (SFTP) are rare neoplasms derived from mesenchymal cells of the pleura. A 63-year-old male patient, laborer by profession, presented with progressive dry cough and breathlessness for one month. Clinically he had left-sided intrathoracic mass which was confirmed by CT thorax.
View Article and Find Full Text PDFA Case Involving Linezolid-induced Fatal Lactic Acidosis and Pancytopenia.
J Assoc Physicians India
November 2024
Article Synopsis
- A 77-year-old woman with multidrug-resistant pulmonary tuberculosis was treated with a long oral regimen based on Indian PMDT guidelines for one month.
- She experienced severe side effects including nausea, vomiting, and breathing difficulties, along with blood-related issues and rising lactate levels.
- Despite thorough investigations and treatment, she unfortunately died from severe lactic acidosis linked to her linezolid medication.
Hip replacement is a common orthopedic surgery in the aging population. With the rising incidence of prostate cancer, metallic hip prosthetics can cause considerable beam hardening and streak artifacts, leading to difficulty in identifying the target volumes and planning process for radiation treatment. The growing use of Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer is now well established.
View Article and Find Full Text PDFIntroduction: Surface mold brachytherapy (SMBT) is an established treatment modality in skin cancer, especially in accessible areas, and has shown comparable outcomes to surgery. We have presented our results for the skin tumor treatment with SMBT treated with high-dose-rate (HDR) brachytherapy in terms of clinical outcomes and toxicity at our institute.
Materials And Methods: In this retrospective analysis, 15 patients with skin cancer were treated with customized tube-based SMBT at our institute between January 2019 and July 2021.
Article Synopsis
- Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC) did not show improved survival compared to standard chemoradiotherapy, and previous trials did not isolate the impacts of various risk factors.
- A retrospective study of 331 patients with T4 and/or N2 rectal adenocarcinoma indicated that 93.4% achieved R0 resection, with a 3-year overall survival rate of 84%, but different high-risk features resulted in varying clinical outcomes.
- The study found that while adjuvant chemotherapy (ACT) improved survival in the overall cohort and N2 subgroup, it did not benefit those with T4 disease; thus, treatment strategies should be tailored